MedTrace Logo

Physical Exercise Program in Chronic Chagas Heart Disease

NCT02517632 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-07-27

No results posted yet for this study

Summary

The aim of this investigation is to evaluate the impact of exercise in a cardiac rehabilitation program on functional capacity, clinical markers, quality of life and biomarkers in patients with chronic chagasic cardiomyopathy.

Conditions

  • Chagas Disease
  • Chagas Cardiomyopathy

Interventions

BEHAVIORAL

Exercise, nutritional and pharmaceutical counceling

The exercise group will be submitted to a physical exercise intervention protocol performed three times per week, 60 minutes per session, during 6-month period, and a monthly counseling from pharmaceutical and nutritional professionals provided during the follow-up and consisted on general guidance about healthy eating habits for patients with heart failure, mainly sodium and water intake, and medication usage, particularly drug dosage and compliance.

BEHAVIORAL

Nutritional and pharmaceutical counceling

The control group will be submitted to a monthly counseling from pharmaceutical and nutritional professionals provided during the follow-up and consisted on general guidance about healthy eating habits for patients with heart failure, mainly sodium and water intake, and medication usage, particularly drug dosage and compliance.

Sponsors & Collaborators

  • National Institute of Cardiology, Laranjeiras, Brazil

    collaborator OTHER_GOV

  • Evandro Chagas National Institute of Infectious Disease

    lead OTHER

Principal Investigators

  • Fernanda Mendes, M.D. · Evandro Chagas National Institute of Infectious Disease

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02517632 on ClinicalTrials.gov